Women at high risk of developing breast cancer are a heterogeneous group of women
including those with and without high-risk germline mutation/s. Prevention in these women …

Background Most clinical breast changes in women are benign; in only 3% to 6% of cases
are they due to breast cancer. However, there is a lack of up-to-date, evidence-based …

Importance Breast cancer is a leading cause of premature mortality among US women. Early
detection has been shown to be associated with reduced breast cancer morbidity and …

ABSTRACT The 14th St Gallen International Breast Cancer Conference (2015) reviewed
substantial new evidence on locoregional and systemic therapies for early breast cancer …

Importance A breast pathology diagnosis provides the basis for clinical treatment and
management decisions; however, its accuracy is inadequately understood. Objectives To …

An estimated 60,290 new cases of breast carcinoma in situ are expected to be diagnosed in
2015, and approximately 1 in 33 women is likely to receive an in situ breast cancer …

Purpose The increased breast cancer risk conferred by a diagnosis of lobular carcinoma in
situ (LCIS) is poorly understood. Here, we review our 29-year longitudinal experience with …

Inflammation is now recognized as a hallmark of cancer. Genetic changes in the cancer cell
are accepted as the match that lights the fire, whilst inflammation is seen as the fuel that …

Objective Review evidence to guide management of menopausal signs and symptoms in
women after breast cancer and make recommendations accordingly. Evidence Randomized …

The heterogeneous group of B3 lesions in the breast harbors lesions with different
malignant potential and progression risk. As several studies about B3 lesions have been …